| Bioactivity | LG 6-101 is an orally active and new antiarrhythmic agent. LG 6-101 shows strong antiarrhythmic effects in a coronary-artery-ligation model of rats, better than Propafenone (HY-B0432). LG 6-101 also delays the occurence of ventricular premature beat (VPB)'s and has protective effects against cardiac arrest caused by infusion of aconitine[1][2]. |
| CAS | 132798-26-6 |
| Formula | C22H32ClNO3S |
| Molar Mass | 426.01 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Wascher TC, et al. LG 6-101 and LG 6-102, two new propafenone-related antiarrhythmic agents with good oral activity in rats. Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):473-7. [2]. Wascher TC, et al. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia. Arzneimittelforschung. 1991 Feb;41(2):119-24. |
LG 6-101
CAS: 132798-26-6 F: C22H32ClNO3S W: 426.01
LG 6-101 is an orally active and new antiarrhythmic agent. LG 6-101 shows strong antiarrhythmic effects in a coronary-ar
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.